← Leaderboards
Scott Matthew Ebert
Emmyon, Inc.
$1,877,329
Attributed
$6,602,479
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,602,479 · 7
By mechanism
R44$5,992,477 · 4
R43$385,002 · 2
R41$225,000 · 1
Top collaborators
- Christopher M Adams10 shared
- John Jeffrey Talley9 shared
- Andrew Robert Judge2 shared
- Sarah M Judge2 shared
- Aleksey V Matveyenko1 shared
Others in their field
Top investigators on “Medical”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$422,116,177
- Richard K. Wilson · Washington University$281,315,172
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$275,147,130
Research focus
MedicalLeadProgramsSafetyChemistryMedicineMuscular AtrophyLegal PatentSeriesPharmaceutical PreparationsMouse ModelPharmacologic SubstanceAffectFda ApprovedSmall Business Innovation Research GrantMrna ExpressionMuscle FormSkeletal MuscleDesignPreventQuality Of LifeAtrophicAdvanced DevelopmentMortality
Grant awards (10)
Development of novel therapeutics for obesity and type 2 diabetes$1,021,719
R44 · FY2025 · DK · contact PI
Development of novel therapeutics for cancer cachexia$997,245
R44 · FY2024 · CA · contact PI
Development of novel therapeutics for cancer cachexia$990,411
R44 · FY2023 · CA · contact PI
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$745,404
R44 · FY2021 · AR · contact PI
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$745,404
R44 · FY2020 · AR · contact PI
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$746,147
R44 · FY2019 · AG · contact PI
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$746,147
R44 · FY2018 · AG · contact PI
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$225,000
R43 · FY2016 · AR · contact PI
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$225,000
R41 · FY2014 · AG
Development of novel therapies for aging-induced skeletal muscle atrophy.$160,002
R43 · FY2013 · AG · contact PI